LFMD vs. SMED, AUNA, AIRS, SHLT, PTWO, TOI, MRM, NVOS, AIH, and OTRK
Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Sharps Compliance (SMED), Auna (AUNA), AirSculpt Technologies (AIRS), SHL Telemedicine (SHLT), Pono Capital Two (PTWO), Oncology Institute (TOI), MEDIROM Healthcare Technologies (MRM), Novo Integrated Sciences (NVOS), Aesthetic Medical International Holdings Group (AIH), and Ontrak (OTRK).
Sharps Compliance (NASDAQ:SMED) and LifeMD (NASDAQ:LFMD) are both small-cap industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
Sharps Compliance has a net margin of 7.88% compared to Sharps Compliance's net margin of -14.75%. LifeMD's return on equity of 5.48% beat Sharps Compliance's return on equity.
Sharps Compliance received 213 more outperform votes than LifeMD when rated by MarketBeat users. However, 71.79% of users gave LifeMD an outperform vote while only 51.72% of users gave Sharps Compliance an outperform vote.
56.1% of Sharps Compliance shares are owned by institutional investors. Comparatively, 35.5% of LifeMD shares are owned by institutional investors. 4.8% of Sharps Compliance shares are owned by company insiders. Comparatively, 18.9% of LifeMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Sharps Compliance has higher earnings, but lower revenue than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Sharps Compliance, indicating that it is currently the more affordable of the two stocks.
In the previous week, LifeMD had 5 more articles in the media than Sharps Compliance. MarketBeat recorded 5 mentions for LifeMD and 0 mentions for Sharps Compliance. Sharps Compliance's average media sentiment score of 0.85 beat LifeMD's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.
LifeMD has a consensus price target of $12.50, suggesting a potential upside of 65.78%. Given Sharps Compliance's higher possible upside, analysts plainly believe LifeMD is more favorable than Sharps Compliance.
Sharps Compliance has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500.
Summary
Sharps Compliance beats LifeMD on 10 of the 17 factors compared between the two stocks.
Get LifeMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
